HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rational approach to the antibiotic treatment of pneumonia in the elderly.

Abstract
The incidence of pneumonia is highest among the aged compared with other adult populations, and causes significant morbidity and mortality among this group. Most episodes of pneumonia are caused by aspiration of oropharyngeal flora into the lungs and failure of lung defence mechanisms to eliminate the aspirated bacteria. Studies in elderly patients have shown a high rate of oropharyngeal carriage of Gram-negative bacilli and polymicrobial/mixed flora pneumonias, especially in debilitated elderly patients in nursing homes or hospitals. This information is helpful to practitioners in prescribing empirical antibiotic therapy for elderly patients with pneumonia. Because of the many additional concerns which must be considered in the rational selection of an antibiotic regimen, e.g. route of administration, compliance, drug pharmacokinetics and pharmacodynamics, drug toxicity, and drug-disease interactions, it is also helpful for practitioners to become familiar with a small number of the large group of available antibiotics. Based on these considerations and the presumed bacteriology of pneumonia in the elderly in the 3 clinical settings (community, nursing home and hospital), a limited number of antibiotics are recommended for empirical antibiotic regimens for elderly patients with pneumonia. In particular, beta-lactamase inhibitors and cotrimoxazole (trimethoprim-sulfamethoxazole) are recommended, with ciprofloxacin as an alternative agent. There is a limited role for third-generation cephalosporins and extended-spectrum penicillins. Aminoglycosides are only recommended for patients with pneumonia in the intensive care unit on mechanical ventilation. Monotherapy (single agent) should be used whenever possible.
AuthorsJ M Mylotte, S Ksiazek, D W Bentley
JournalDrugs & aging (Drugs Aging) Vol. 4 Issue 1 Pg. 21-33 (Jan 1994) ISSN: 1170-229X [Print] New Zealand
PMID8130380 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Aged
  • Aging (drug effects, metabolism)
  • Anti-Bacterial Agents (administration & dosage, pharmacokinetics, therapeutic use)
  • Decision Making
  • Drug Interactions
  • Hospitalization
  • Humans
  • Nursing Homes
  • Pneumonia (drug therapy, epidemiology, etiology)
  • Risk Factors
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: